5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.45▲ | 1.45▲ | 1.45▲ | 1.47▲ | 1.53▲ |
MA10 | 1.54▼ | 1.52▼ | 1.52▼ | 1.49▲ | 1.67▼ |
MA20 | 1.53▼ | 1.52▼ | 1.53▼ | 1.52▲ | 1.79▼ |
MA50 | 1.53▼ | 1.58▼ | 1.64▼ | 1.74▼ | 2.28▼ |
MA100 | 1.70▼ | 1.75▼ | 1.77▼ | 1.84▼ | 2.15▼ |
MA200 | 1.80▼ | 1.88▼ | 1.93▼ | 2.19▼ | 3.74▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.016▼ | -0.002▼ | 0.000▼ | 0.015▲ | -0.014▼ |
RSI | 46.888▼ | 47.240▼ | 46.524▼ | 50.524▲ | 40.782▼ |
STOCH | 11.691▼ | 17.509▼ | 17.509▼ | 25.688 | 21.397 |
WILL %R | -83.544▼ | -79.518▼ | -79.518▼ | -58.621 | -73.016 |
CCI | -63.329 | -18.337 | -17.735 | 76.246 | -82.360 |
Monday, April 28, 2025 05:00 AM
Biotech luminary to mentor C-suite and provide strategic guidance - SAN DIEGO and SUZHOU, China, April 28, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the ...
|
Sunday, April 27, 2025 10:00 PM
SAN DIEGO and SUZHOU, China, April 28, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of antibody-based therapies ...
|
Wednesday, April 23, 2025 05:00 PM
SAN DIEGO and SUZHOU, China, April 23, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.55 | 1.6262 | 1.53 | 1.58 | 15,705 |
30/04/25 | 1.45 | 1.54 | 1.435 | 1.52 | 18,247 |
28/04/25 | 1.44 | 1.45 | 1.41 | 1.43 | 17,269 |
25/04/25 | 1.39 | 1.45 | 1.39 | 1.42 | 37,935 |
24/04/25 | 1.41 | 1.44 | 1.36 | 1.39 | 5,912 |
23/04/25 | 1.41 | 1.5348 | 1.41 | 1.48 | 1,259 |
22/04/25 | 1.51 | 1.555 | 1.43 | 1.45 | 12,218 |
21/04/25 | 1.54 | 1.60 | 1.53 | 1.55 | 2,462 |
17/04/25 | 1.662 | 1.662 | 1.50 | 1.53 | 12,317 |
16/04/25 | 1.60 | 1.92 | 1.52 | 1.58 | 21,428 |
|
|
||||
|
|
||||
|
|